<DOC>
	<DOCNO>NCT01332097</DOCNO>
	<brief_summary>This study assess preliminary parameter safety efficacy single dose BCT197 patient Chronic Obstructive Pulmonary Disease ( COPD ) exacerbation .</brief_summary>
	<brief_title>Safety &amp; Efficacy BCT197A2201 Chronic Obstructive Pulmonary Disease ( COPD ) Patients Presenting With Exacerbation</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>Patients COPD ( Stage II IV ) COPD exacerbation . Smoking history 10 pack year . Females must childbearing potential . Use steroids last 30 day calcium channel blocker last 48 hour . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>Exacerbation</keyword>
	<keyword>Pulmonary Inflammation</keyword>
</DOC>